Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	143.82	188.66	764.68	850.12	21.66	34.49
Short-Term Investments	434.28	458.25	0	0	0	0
Cash & Cash Equivalents	578.11	646.91	764.68	850.12	21.66	34.49
Cash Growth	-10.64%	-15.40%	-10.05%	3824.64%	-37.20%	-
Receivables	0	0	0	5.82	0	0
Other Current Assets	12.35	14.02	7.72	7.55	0.25	0.21
Total Current Assets	590.46	660.92	772.4	863.48	21.91	34.7
Property, Plant & Equipment	3.12	4.09	0.18	0.05	0.04	0.06
Other Long-Term Assets	1.4	1.69	0.31	0.11	0.12	0.11
Total Long-Term Assets	4.51	5.79	0.49	0.16	0.16	0.16
Total Assets	594.97	666.71	772.89	863.63	22.07	34.86
Accounts Payable	4.25	2.55	4.53	0.06	0.55	0.39
Deferred Revenue	0	0	0	301.37	0	0
Current Debt	0.76	0.72	0.2	0	0	0
Other Current Liabilities	27.36	15.21	52.15	14.37	1.89	1.37
Total Current Liabilities	32.38	18.48	56.88	315.8	2.44	1.76
Long-Term Debt	1.64	2.4	0	0	0	0
Other Long-Term Liabilities	5.76	5.26	5.93	0.04	0.1	0.15
Total Long-Term Liabilities	7.4	7.66	5.93	0.04	0.1	0.15
Total Liabilities	39.78	26.14	62.82	315.83	2.53	1.91
Total Debt	2.4	3.12	0.2	0	0	0
Debt Growth	-23.11%	1485.79%	-	-	-	-
Retained Earnings	-195.84	-59.88	56.03	-65.16	-54.21	-40.18
Comprehensive Income	0.21	-0.68	0	0	0	0
Shareholders' Equity	555.19	640.57	710.08	547.8	-49.57	-36.16
Net Cash / Debt	575.7	643.78	764.48	850.12	21.66	34.49
Net Cash / Debt Growth	-10.57%	-15.79%	-10.07%	3824.64%	-37.20%	-
Net Cash Per Share	6.90	7.73	8.66	39.37	2.15	3.44
Working Capital	558.08	642.44	715.52	547.68	19.48	32.94
Book Value Per Share	6.66	7.70	8.57	25.37	-4.91	-3.60

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).